MetLife Investment Management’s Infinera Corporation Common Stock INFN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-118,124
| Closed | -$776K | – | 2835 |
|
|
2024
Q4 | $776K | Buy |
118,124
+6,383
| +6% | +$42.5K | ﹤0.01% | 1552 |
|
|
2024
Q3 | $754K | Hold |
111,741
| – | – | ﹤0.01% | 1555 |
|
|
2024
Q2 | $681K | Buy |
111,741
+19,544
| +21% | +$103K | ﹤0.01% | 1550 |
|
|
2024
Q1 | $556K | Sell |
92,197
-9,098
| -9% | -$45.7K | ﹤0.01% | 1615 |
|
|
2023
Q4 | $481K | Hold |
101,295
| – | – | ﹤0.01% | 1710 |
|
|
2023
Q3 | $423K | Hold |
101,295
| – | – | ﹤0.01% | 1729 |
|
|
2023
Q2 | $489K | Buy |
101,295
+2,590
| +3% | +$14.2K | ﹤0.01% | 1705 |
|
|
2023
Q1 | $766K | Hold |
98,705
| – | – | 0.01% | 1381 |
|
|
2022
Q4 | $665K | Hold |
98,705
| – | – | 0.01% | 1462 |
|
|
2022
Q3 | $478K | Buy |
98,705
+7,410
| +8% | +$40.6K | ﹤0.01% | 1670 |
|
|
2022
Q2 | $489K | Sell |
91,295
-6,348
| -7% | -$40.6K | ﹤0.01% | 1677 |
|
|
2022
Q1 | $847K | Buy |
97,643
+34,680
| +55% | +$298K | 0.01% | 1442 |
|
|
2021
Q4 | $604K | Buy |
62,963
+9,213
| +17% | +$78.1K | 0.01% | 1411 |
|
|
2021
Q3 | $447K | Sell |
53,750
-9,695
| -15% | -$87.9K | ﹤0.01% | 1577 |
|
|
2021
Q2 | $647K | Buy |
63,445
+12,440
| +24% | +$121K | 0.01% | 1423 |
|
|
2021
Q1 | $491K | Sell |
51,005
-15,151
| -23% | -$148K | ﹤0.01% | 1533 |
|
|
2020
Q4 | $693K | Sell |
66,156
-248
| -0.4% | -$1.97K | 0.01% | 1309 |
|
|
2020
Q3 | $409K | Sell |
66,404
-10,792
| -14% | -$75.5K | ﹤0.01% | 1474 |
|
|
2020
Q2 | $457K | Hold |
77,196
| – | – | 0.01% | 1425 |
|
|
2020
Q1 | $409K | Hold |
77,196
| – | – | 0.01% | 1317 |
|
|
2019
Q4 | $613K | Hold |
77,196
| – | – | 0.01% | 1347 |
|
|
2019
Q3 | $421K | Sell |
77,196
-22,223
| -22% | -$97.7K | ﹤0.01% | 1519 |
|
|
2019
Q2 | $289K | Buy |
99,419
+32,776
| +49% | +$123K | ﹤0.01% | 1810 |
|
|
2019
Q1 | $289K | Hold |
66,643
| – | – | ﹤0.01% | 1772 |
|
|
2018
Q4 | $266K | Hold |
66,643
| – | – | ﹤0.01% | 1749 |
|
|
2018
Q3 | $486K | Hold |
66,643
| – | – | 0.01% | 1564 |
|
|
2018
Q2 | $662K | Hold |
66,643
| – | – | 0.01% | 1238 |
|
|
2018
Q1 | $724K | Hold |
66,643
| – | – | 0.01% | 1157 |
|
|
2017
Q4 | $422K | Buy |
+66,643
| New | +$508K | ﹤0.01% | 1496 |
|
Other funds holding INFN
MetLife Investment Management's INFN Position: Q1 2025 in Review
MetLife Investment Management sold out of Infinera Corporation Common Stock (INFN) in Q1 2025, closing a stake of 118,124 shares — an estimated $776K sold.
MetLife Investment Management first reported a position in INFN in Q4 2017 and held it in 29 quarters. The position peaked at $847K in Q1 2022. 4 funds tracked by Wall St. Rank hold INFN as of Q1 2025.
- MetLife Investment Management reported no remaining Infinera Corporation Common Stock position as of Q1 2025 after selling out during the quarter.
- MetLife Investment Management sold 118,124 Infinera Corporation Common Stock shares in Q1 2025, an estimated $776K.
- MetLife Investment Management first reported a position in Infinera Corporation Common Stock in Q4 2017 and held it in 29 quarters.
- MetLife Investment Management's Infinera Corporation Common Stock position peaked at $847K in Q1 2022.
- 4 funds tracked by Wall St. Rank held Infinera Corporation Common Stock as of Q1 2025.
Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.